NoMy Secures €1.25M to Commercialize Mycoprotein Technologies Using Resources From Beet Sugar Manufacturing

Norwegian Mycoprotein (NoMy) has secured €1.25 million in funding from investors such as Nippon Beet Sugar Manufacturing Co., Ltd. The funding will allow NoMy to scale the deployment of its mycoprotein technologies in order to improve sustainability and diversity in the food and feed industry. This partnership with Nitten aims to commercialize NoMy's mycoprotein technologies using resources from beet sugar manufacturing, providing a solution to the global protein supply shortage.

NoMy uses fungal fermentation technology to turn food industry side-streams into high-value ingredients, resulting in mycoprotein that is packed with high-quality protein, fiber, and minerals. Co-founded by Ingrid Dynna and David Andrew Quist, NoMy aims to create a circular food system and has a deep commitment to sustainability. The funding will further support NoMy's collaboration with Nitten Sugar and its mission to revolutionize protein supplies in the food industry.